MEB appoints US med-tech veteran as CEO & Managing Director
Filed with ASX · · 2 pages · English
Earlier from TrivarX
- Early Redemption of Convertible Note
- Partnership with leading US University on PTSD
- Excellent performance in the pilot phase of US Validation
- Medibio enters into binding agreement with Medtronic
- Capital raising of $13.5million to accelerate growth
Later from TrivarX
- Conversion of Options to Partly Paid shares
- MEB enters fully funded Paediatric mental illness diagnostic
- Quarterly ASX Update and Cashflow
- MEB Signs Strategic Joint Development Agreement with Mayo Cl
- Signed second agreement for Wellness
Follow TrivarX into a list and get an email when it puts out news.
Follow TrivarX